The Role of Human Papillomavirus in Bowenoid Papulosis

Yuli Wahyu Rahmawati; Dwi Murtiastutik; Sjahjenny Mustokoweni

doi:10.20473/bikk.V29.3.2017.253-259

Authors

Yuli Wahyu Rahmawati Departemen/Staf Medik Fungsional Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Airlangga/Rumah Sakit Umum Daerah Dr. Soetomo Surabaya, Indonesia
Dwi Murtiastutik
dwimurtiastutik@yahoo.co.id
Departemen/Staf Medik Fungsional Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Airlangga/Rumah Sakit Umum Daerah Dr. Soetomo Surabaya, Indonesia
Sjahjenny Mustokoweni Departemen/Staf Medik Fungsional Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Airlangga/Rumah Sakit Umum Daerah Dr. Soetomo Surabaya, Indonesia

Vol. 29 No. 3 (2017): DESEMBER

Research

Downloads

PDF

Abstract
How to Cite
Metrics
References
License

Background: Human Papillomavirus (HPV) infection can be associated with a variety of cutaneous as well as mucosal manifestations. Some types of HPV are associated with increased risk of epithelial malignancies; these have been divided into low-risk and high-risk types based on their oncogenic potential. Bowenoid papulosis (BP) strongly associated with high risk type. Purpose: To provide information to health workers, in order to be more concern about BP.Review: The term BP refers to multifocal papular lesions on the genitalia with histological features similar to squamous cell carcinoma (SCC) in situ or Bowen’s Disease (BD). Its clinical manifestation is characterized by multiple brownish or erythematous papules located in the anogenital region, affecting mostly young adults with an active sex life. Clinically, it must be differentiated from seborrheic keratosis, and melanocytic nevus. Bowenoid papulosis is strongly associated with HPV 16.Conclusion: The natural course of BP is unpredictable, the lesions may increase, decrease, and even disappear spontaneously. Progression to an invasive SCC has been estimated in 2.6% of cases, HPV type 16 is the most frequent causative agent of BP.

Rahmawati, Y. W., Murtiastutik, D., & Mustokoweni, S. (2017). The Role of Human Papillomavirus in Bowenoid Papulosis. Berkala Ilmu Kesehatan Kulit Dan Kelamin, 29(3), 253–259. https://doi.org/10.20473/bikk.V29.3.2017.253-259

Download Citation

Calonje C. Cutaneous manifestations of human papillomaviruses: A review. Acta Dermatoven APA 2011;3(20):145-54.

Androphy JE, Kirnbaurer R. Human papillomavirus infections. In: Goldsmith Al, Katz S, Gilchrest A, Paller A, Leffell D, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: Mc Grawhill; 2012. p. 2421-32.

Letto P, Porro M, Junior G, Tomimori. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol 2011;86(2):306-17.

Marcucci C, Sabban EC, Friedman P, Peralta R, Calb I, Cabo H. Dermoscopic findings in bowenoid papulosis: report of two cases. Dermatol Pract Concept 2014;4(4):11-24.

Kao GF, Cerro R, Salon R, Pala S. Bowenoid Papulosis. In: LeBruit G, Weedon D, Burg G, Sarasin A, editors. Pathologic and Genetic Skin Tumors Lyon: IARC Press; 2006. p. 27-45.

Weedon D. Tumors. In: Weedon D, editors. Skin Pathology. 3th ed. Sydney; Elseiver: 2010. p. 645-78.

Allan S. Bowen disesase In: Kempf W, Hanschke T, Kutzner, Burdgorf editors. Dermathopathology.1st ed. Wurtzburg: Elseiver; 2008. p. 645-78.

Kaneko T, Nakashi G, Nakajima K, Aizu T, Jin K, Rokunhe D, et al. Amplification of papillomavirus oncogenic transcripts assay for bowenoid papulosis. IJCM 2013; 4: 428-31.

Zaravinos A, Mammas IN, Sourvinos S, Sapdidos DA. Molecular detection methods of human papillomavirus. Inter J Biol Marker 2009; 24 (4): 215-22.

Gutierrez-Xicotencati L, Plett-Torres T, Madrid-Gonzales CL, Madrid-Marina V. Molecular diagnosis of human papillomavirus in the development of cervical cancer. Salud Publica Mex 2009; 51 (Supp 3): 1-10.

Dalianis T. Human papillomavirus and oropharyngeal cancer, the epidermis, and significance of additional clinical biomarker for prediction of respons therapy. Int J Oncol 2014: 1-7.

Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. MMBR 2004; 68(2):362.

Izadi-Mood N, Asadi K, Shojaei H, Sarmadi S, Ahmadi SA, Sani S, et al. Potential diagnostic value of p16 expression in premalignant and malignant cervical lesions. J Res Med Sci 2012; 17(5): 428–33.

Auepemkiate, Thongsuksai, Boonyaphiphat. P16INK4A Expression in Bowen’s disease and Bowenoid papulosis. J Med Assoc Thai 2006; 89 (9): 1460-5

Bunker C. Diseases and disorders of the male genitalia. In: Goldsmith Al, Katz S, Gilchrest A, Paller A, Leffell D, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: Mc Grawhill; 2012. p. 852-78.

Kaneko T, Nakashi G, Nakajima K, Aizu T, Jin K, Rokunhe D, et al. Amplification of

papillomavirus oncogenic transcripts assay for bowenoid papulosis. IJCM 2013; 4: 428-31.

Champione E, Centonez C, Diluvio L, Orlandi A, Cipriani C, Stefani A, et Al. Bowenoid Papulosis and invasive bowen’s disease: A multidisciplinary approach. Acta Derm Venereol 2013; 93: 216-56.

Peng WS, Tan C. Bowenoid papulosis in a linear distribution. Adv Dermatol Allergol 2016; 33(2): 146–8.

Du J, Lu X, Liang J, Yang Y, Lin J, Zhu X, et al. Detection and typing of human papillomavirus (HPV) in condyloma acuminatum and bowenoid papulosis HybriBio HPV GenoArray test kit, real-time polymerase chain reaction (PCR) and sequencing. AAJP 2013; 7(3); 73-7

Bakardzhiev I, Pehlivanov G, Stransky D, Gonevski M. Treatment of condylomata acuminata and bowenoid papulosis with CO2 laser and imiquimod. J of IMAB 2012; 18(1): 246-49.

Patel RV, Yanofsky VR, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol 2012; 5(6): 25-36.

The Role of Human Papillomavirus in Bowenoid Papulosis

Authors

Downloads

Most read articles by the same author(s)

Journal Policy

EditorialTeam

Meet Our Editorial Team

Instruction for Author

People

Accreditation Certificate

Tools

Visitors

Visitors

ISSN

Indexed In

Indexed In

Citations

Address

Contact Info: